advertisement

SEC recommends Phase 1 trials of Reliance's Covid vaccine candidate

India Today Television
New Delhi,UPDATED: Aug 27, 2021 15:56 IST

The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance Life Sciences' two-dose Covid-19 vaccine candidate. Now, approval by the Drugs Controller General of India (DCGI) is required, following which Reliance Life Sciences can commence Phase 1 trials of the Covid-19 vaccine.

Read more!
More videos from Coronavirus Outbreak

VIDEOS FROM OTHER SECTIONS

ProgrammeIndia First

LATEST VIDEOS

advertisement
advertisement